This article was originally published in The Gray Sheet
Executive SummarySecurities and Exchange Commission concludes investigation into company's restatement of fiscal 1994 and 1995 results with administrative order requiring Sunrise to cease and desist from reporting and record-keeping violations "without admitting or denying" the SEC's conclusions or findings of fact, Sunrise announces Feb. 25. The company's restatements were related to accounting irregularities at its Bio Clinic subsidiary ("The Gray Sheet" Jan. 8, 1996, I&W-11)
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.